Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Personalizing Your Semaglutide Timeline With PlexusDx The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
This proprietary tool leverages purchase data from relevant existing shopper personalities, including Protein Seekers, Low-Carb Seekers, Weight Loss Viewers, and High Fiber Seekers
A 2022 analysis in Pharmacotherapy found that pharmacist-led medication review at GLP-1 initiation identified a clinically significant interaction concern in 14% of patients, the most common being an oral contraceptive or levothyroxine combination [13]
Clinical Evidence Clinical studies have consistently demonstrated the efficacy of GLP-1 agonists in improving metabolic parameters and promoting weight loss: Weight Loss: Patients treated with GLP-1 agonists often experience significant reductions in body weight compared to those receiving placebo or other treatments
View source Yao-Yi Kuo, Hao-Yun Chang, Yu-Chen Huang, Che-Wei Liu
doi: 10.1055/s-0032-1328877 44 KhorramiAGhanbarzadehSZiaeeMAramiSVajdiRGarjaniA
US$ 24.50
US$ 29.83
US$ 28.57
US$ 25.41
